Skip to main content

Table 1 Clinicopathological features of patients

From: Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy

  Median (range)
Age 66 (52–74)
Preoperative serum PSA (ng/ml) 10.3 (0.2-118.0)
  % (n)
Preoperative serum PSA  
 <10 ng/ml 41.7 (35)
 ≥10 ng/ml 58.3 (49)
Gleason score  
 <7 28.6 (24)
 7 47.6 (40)
 >7 23.8 (20)
Clinical T stage  
 I 56 (47)
 II 44 (37)
Pathological T stage  
 II 64.3 (54)
 III 32.1 (27)
 IV 3.6 (3)
Node involvement 7.1 (6)
Positive surgical margins 41.7 (35)
Perineural invasion 17.9 (15)
Total Biochemical progression 40.5 (34)
 at 5 years 38.1 (32)
 5 - 10 years 2.4 (2)
Survival 64.7a(22)
Deaths 35.3a(12)
  1. aExpressed respect total biochemical progressión